Back to search results

Study of Questionnaires in Adolescents and Young Adults With Cancer

This study is looking at questionnaires for adolescents and young adults (ages 15-39) who have cancer. The main goal is to check how reliable a questionnaire called PRO-AYA (Patient-Reported Outcomes for Adolescents and Young Adults) is, and to make sure a Spanish version of it works well for Spanish-speaking patients. You can join if you are between 15 and 39, have been diagnosed with cancer, and can speak English or Spanish. The study is considered successful if the questionnaires are found to be reliable and the Spanish version is validated. The current recruitment status is unclear.

Study design
This is an observational study that plans to enroll 120 participants. It is not specified if it is randomized or blinded.
What's involved
You would complete questionnaires, including PRO-AYA, Patient-Reported ECOG PS, and EORTC QLQ-C30. For some participants, this would also involve a cognitive interview for the Spanish PRO-AYA. These assessments would be measured at up to one month.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured at up to one month.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07212166

A Study of Questionnaires in Adolescents and Young Adults With Cancer

Recruiting
Not specifiedAges 15–39Observational
Memorial Sloan Kettering Cancer Center
~120 participants
Updated 2026-08-04 on ClinicalTrials.gov
What's tested:Patient-Reported Outcome SurveysSpanish version of PRO-AYA and the cognitive interview

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Test-retest reliability
Measured over up to one month
+1 more outcome measured

Conditions

Adolescents and Young Adults With Cancer

Explore related trials

Malignant Neoplasm

Where it's being run

7 sites across 2 states
New York4
New Jersey3

Study leadership

  • Thomas Atkinson, PhD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Thomas Atkinson, PhD
[email protected]
646-888-0089
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English- or Spanish proficient
Between the ages of 15-39
Diagnosed with cancer or the recurrence of a cancer as per clinician report and/or received active treatment for cancer between the ages of 15-39
Able to complete questionnaires by themselves or with assistance as per self-report
For Cohort 1 ONLY:
3 months from last treatment without plan to initiate any form of cancer-directed treatment in the next 3 months OR
On chronic cancer-directed therapy for the last 3 months without plan to change cancer-directed therapy in the next 3 months AND
ECOG Performance Status (0-4) or KPS/Lansky Score (0-100)

What this trial measures

  • Test-retest reliabilityup to one month

    The test-retest reliability will be based on the intraclass correlation (ICC) coefficients between the baseline and follow-up domain scores of PRO-AYA.

  • Linguistically validate PRO-AYA or patients who prefer their healthcare be delivered in Spanish. (Cohort 2)up to a month

    The primary goal of these cognitive interviews is to ensure that the wording and/or phrasing of the instructions, questions and answer choices are appropriate for native Spanish-speakers. The wording and phrasing are a result of direct translation of the English version of the PRO-AYA to a Spanish version.